---
$id: https://graph.org.ai/products/commodity/51321813
$type: Product
source: UNSPSC
code: "51321813"
title: "Serfibrate"
class: "51321800"
classTitle: "Antihyperlipidemic and hypocholesterolemic fibric acids"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Serfibrate

**UNSPSC Code**: 51321813
**Class**: [Antihyperlipidemic and hypocholesterolemic fibric acids](Antihyperlipidemic and hypocholesterolemic fibric acids.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 910906N64M. European Medicines Agency schedules Serfibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10492MIG. Serfibrate generally arises in the molecular formula C16H20CLNO5S. The term SERFIBRATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) SERFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule serfibrate under HS 29309085 and SITC 51549. As of Q4 2014, SERFIBRATE remains the US FDA Preferred Term for this commodity. Serfibrate bears US NLM identifiers UMLS ID C2348187 and NCI Concept Code C72997. SMILES: Clc1ccc(OC(C(=O)SCC(NC(=O)C)CC(=O)O)(C)C)cc1.

